Gene testing firm 23andMe said on Sunday it had filed for Chapter 11 bankruptcy protection in order to facilitate its sale, after years of struggling to find a sustainable business model.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback